DOI: 10.1007/bf00735923. Cellular pharmacokinetics of doxorubicin in patients with chronic lymphocytic leukemia: comparison of bolus administration and continuous infusion

Cellular pharmacokinetics of doxorubicin in patients with chronic lymphocytic leukemia: comparison of bolus administration and continuous infusion

10.1007/bf00735923

Crossref journal-article

Springer Science and Business Media LLC

Cancer Chemotherapy and Pharmacology (297)

Bibliography

Muller, C., Chatelut, E., Gualano, V., De Forni, M., Huguet, F., Attal, M., Canal, P., & Laurent, G. (1993). Cellular pharmacokinetics of doxorubicin in patients with chronic lymphocytic leukemia: comparison of bolus administration and continuous infusion. Cancer Chemotherapy and Pharmacology, 32(5), 379â384.

Authors 8

Catherine Muller (first)
Etienne Chatelut (additional)
Virginie Gualano (additional)
Marcel De Forni (additional)
Françoise Huguet (additional)
Michel Attal (additional)
Pierre Canal (additional)
Guy Laurent (additional)

References 21 Referenced 40

Andersson B, Beran M, Peterson C, Tribukait B (1982) Significance of cellular pharmacokinetics for the cytotoxic effects of Daunorubicin. Cancer Res 42: 178 / Cancer Res by B Andersson (1982)
Barlogie B, Smith L, Alexanian R (1984) Effective treatment of advanced multiple myeloma refractory to alkalating agents. N Engl J Med 310: 1353 (10.1056/NEJM198405243102104) / N Engl J Med by B Barlogie (1984)
Binet JL, Auquier A, Dighiero G, Chastang C, Piquey H, Goastguen J, Vaugier G, Potron G, Colona P, Oberling F, Thomas M, Tchernia G, Jacquillat C, Boivin P, Lesty C, Duault MT, Monconduit M, Belabbes S, Gremy F (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48: 198 (10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V) / Cancer by JL Binet (1981)
Bonadonna G (1985) Chemotherapy of malignant lymphomas. Sem Oncol 12: 1 / Sem Oncol by G Bonadonna (1985)
Canal P, Sqalli A, De Forni M, Chevreau C, Pujol A, Bugat R, Rocher H, Houstrin J, Houin G (1985) Chronopharmacokinetics of adriamycin in patients with breast cancer. Eur J Clin Pharmacol 40: 287 (10.1007/BF00315211) / Eur J Clin Pharmacol by P Canal (1985)
Coiffier B, Bryon PA, Berger F, Arehimbaud E, French M, Extra JM, Guyotat D, Fiere D, Gentilhomme O, Magaud JP, Blanc M, Peaud PY, Vuvan H, Viala G (1986) Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80). J Clin Oncol 4: 147 (10.1200/JCO.1986.4.2.147) / J Clin Oncol by B Coiffier (1986)
French Cooperative Group on Chronic Lymphocytic Leukemia (1989) Long-term results of the CHOP regimen in stage C chronic lymphocytic leukemia. Br J Hematol 73: 334 (10.1111/j.1365-2141.1989.tb07749.x) / Br J Hematol by French Cooperative Group on Chronic Lymphocytic Leukemia (1989)
Ganapathi R, Reiter W, Krishan A (1982) Intracellular Adriamycin levels and cytotoxicity in Adriamycin-sensitive and Adriamycin-resistant P388 mouse leukemia cells. J Natl Cancer Inst 68: 1027 / J Natl Cancer Inst by R Ganapathi (1982)
Garnick MB, Weiss GR, Steele GD, Israel M, Schade D, Sack MJ, Frei E (1983) Clinical evaluation of long-term continuous-infusion doxorubicin. Cancer Treat Rep 57: 133 / Cancer Treat Rep by MB Garnick (1983)
Herweijer H, Sonneveld P, Baas F, Nooter F (1990) Expression of mdrl and mdr3 multi-drug resistance genes in acute and chronic leukemias and stimulation of drug accumulation by cyclosporine. J Natl Cancer Inst 82: 1133 (10.1093/jnci/82.13.1133) / J Natl Cancer Inst by H Herweijer (1990)
Keating MJ, Kantarjiaian H, Talpaz M, Redman J, Koller C, Barlogie B, Velasquez W, Plunkett W, Freireich EJ, McCredie KB (1989) Fludarabine: a new agent with major activity against chronic lymphocytic leukemia. Blood 74: 19 (10.1182/blood.V74.1.19.bloodjournal74119) / Blood by MJ Keating (1989)
Legha SS, Benjamin RS, Mackay B, Ewer M, Wallace S, Valdivieso M, Rasmussen SL, Blumenschein M, Freireich EJ (1982) Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann Intern Med 96: 133 (10.7326/0003-4819-96-2-133) / Ann Intern Med by SS Legha (1982)
McKelvey EM, Gottlieb JA, Wilson HE, Haut A, Talley RW, Stephens R, Lane M, Gamble JF, Jones SE, Grozea PN, Guttermann J, Coltman C, Moon TE (1976) Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphomas. Cancer 38: 1484 (10.1002/1097-0142(197610)38:4<1484::AID-CNCR2820380407>3.0.CO;2-I) / Cancer by EM McKelvey (1976)
Miller TP, Grogan TM, Dalton WS, Spier CM, Scheper RJ, Salmon SE (1991) P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high dose verapamil. J Clin Oncol 9: 17 (10.1200/JCO.1991.9.1.17) / J Clin Oncol by TP Miller (1991)
Nguyen-Ngoc T, Vrignaud P, Robert J (1984) Cellular pharmacokinetics of doxorubicin in cultured mouse sarcoma cells originating from autochthonous tumors. Oncology 41: 55 (10.1159/000225791) / Oncology by T Nguyen-Ngoc (1984)
Piro LD, Carrera CJ, Beutler E, Carson DA (1988) 2-chloro-deoxyadenosine: an effective new agent for the treatment of chronic lymphocytic leukemia. Blood 72: 1069 (10.1182/blood.V72.3.1069.bloodjournal7231069) / Blood by LD Piro (1988)
Shustik C, Groulx N, Gros P (1991) Analysis of multidrug resistance (MDR-1) gene expression in chronic lymphocytic leukemia (CLL). Br J Haematol 79: 50 (10.1111/j.1365-2141.1991.tb08006.x) / Br J Haematol by C Shustik (1991)
Speth PA, Linssen PC, Boezeman JB, Wessels H, Haanen C (1987a) Cellular and plasma adriamycin concentrations in longterm infusion therapy of leukemia patients. Cancer Chem Pharmacol 20: 305 / Cancer Chem Pharmacol by PA Speth (1987)
Speth PA, Linssen PC, Boezeman JB, Wessels H, Haanen C (1987b) Leukemic cell and plasma daunomycin concentrations after bolus injection and 72 h infusion. Cancer Chem Pharmacol 20: 311 / Cancer Chem Pharmacol by PA Speth (1987)
Speth PA, Linssen PC, Holdriner RS, Haanen C (1987c) Plasma and cellular Adriamycin concentrations in patients with myeloma treated with ninety-six-hour continuous infusion. Clin Pharmacol Ther 41: 661 (10.1038/clpt.1987.92) / Clin Pharmacol Ther by PA Speth (1987)
Velasquez WS, McLaughlin P, Alexanian R, Barlogie B, Swan F, Caballinas F (1988) Combination of dexamethasone, doxorubicin (Adriamycin) and vincristine (VAD) in chronic lymphocytic leukemia and diffuse small lymphocytic lymphoma. Blood 72: 232a / Blood by WS Velasquez (1988)

Dates

Type	When
Created	20 years, 8 months ago (Dec. 3, 2004, 9:12 p.m.)
Deposited	5 years, 4 months ago (April 4, 2020, 9:51 a.m.)
Indexed	54 minutes ago (Aug. 27, 2025, 1:02 a.m.)
Issued	31 years, 11 months ago (Sept. 1, 1993)
Published	31 years, 11 months ago (Sept. 1, 1993)
Published Print	31 years, 11 months ago (Sept. 1, 1993)

Funders 0

None

BibTeX

@article{Muller_1993, title={Cellular pharmacokinetics of doxorubicin in patients with chronic lymphocytic leukemia: comparison of bolus administration and continuous infusion}, volume={32}, ISSN={1432-0843}, url={http://dx.doi.org/10.1007/bf00735923}, DOI={10.1007/bf00735923}, number={5}, journal={Cancer Chemotherapy and Pharmacology}, publisher={Springer Science and Business Media LLC}, author={Muller, Catherine and Chatelut, Etienne and Gualano, Virginie and De Forni, Marcel and Huguet, Françoise and Attal, Michel and Canal, Pierre and Laurent, Guy}, year={1993}, month=sep, pages={379–384} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        8,
        27
      ]
    ],
    "date-time": "2025-08-27T05:02:10Z",
    "timestamp": 1756270930495
  },
  "reference-count": 21,
  "publisher": "Springer Science and Business Media LLC",
  "issue": "5",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            1993,
            9,
            1
          ]
        ],
        "date-time": "1993-09-01T00:00:00Z",
        "timestamp": 746841600000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "http://www.springer.com/tdm"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        1993,
        9
      ]
    ]
  },
  "DOI": "10.1007/bf00735923",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2004,
        12,
        4
      ]
    ],
    "date-time": "2004-12-04T02:12:54Z",
    "timestamp": 1102126374000
  },
  "page": "379-384",
  "source": "Crossref",
  "is-referenced-by-count": 40,
  "title": "Cellular pharmacokinetics of doxorubicin in patients with chronic lymphocytic leukemia: comparison of bolus administration and continuous infusion",
  "prefix": "10.1007",
  "volume": "32",
  "author": [
    {
      "given": "Catherine",
      "family": "Muller",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Etienne",
      "family": "Chatelut",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Virginie",
      "family": "Gualano",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Marcel",
      "family": "De Forni",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Fran\u00e7oise",
      "family": "Huguet",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Michel",
      "family": "Attal",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Pierre",
      "family": "Canal",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Guy",
      "family": "Laurent",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "297",
  "reference": [
    {
      "key": "CR1",
      "first-page": "178",
      "volume": "42",
      "author": "B Andersson",
      "year": "1982",
      "unstructured": "Andersson B, Beran M, Peterson C, Tribukait B (1982) Significance of cellular pharmacokinetics for the cytotoxic effects of Daunorubicin. Cancer Res 42: 178",
      "journal-title": "Cancer Res"
    },
    {
      "key": "CR2",
      "doi-asserted-by": "crossref",
      "first-page": "1353",
      "DOI": "10.1056/NEJM198405243102104",
      "volume": "310",
      "author": "B Barlogie",
      "year": "1984",
      "unstructured": "Barlogie B, Smith L, Alexanian R (1984) Effective treatment of advanced multiple myeloma refractory to alkalating agents. N Engl J Med 310: 1353",
      "journal-title": "N Engl J Med"
    },
    {
      "key": "CR3",
      "doi-asserted-by": "crossref",
      "first-page": "198",
      "DOI": "10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V",
      "volume": "48",
      "author": "JL Binet",
      "year": "1981",
      "unstructured": "Binet JL, Auquier A, Dighiero G, Chastang C, Piquey H, Goastguen J, Vaugier G, Potron G, Colona P, Oberling F, Thomas M, Tchernia G, Jacquillat C, Boivin P, Lesty C, Duault MT, Monconduit M, Belabbes S, Gremy F (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48: 198",
      "journal-title": "Cancer"
    },
    {
      "key": "CR4",
      "first-page": "1",
      "volume": "12",
      "author": "G Bonadonna",
      "year": "1985",
      "unstructured": "Bonadonna G (1985) Chemotherapy of malignant lymphomas. Sem Oncol 12: 1",
      "journal-title": "Sem Oncol"
    },
    {
      "key": "CR5",
      "doi-asserted-by": "crossref",
      "first-page": "287",
      "DOI": "10.1007/BF00315211",
      "volume": "40",
      "author": "P Canal",
      "year": "1985",
      "unstructured": "Canal P, Sqalli A, De Forni M, Chevreau C, Pujol A, Bugat R, Rocher H, Houstrin J, Houin G (1985) Chronopharmacokinetics of adriamycin in patients with breast cancer. Eur J Clin Pharmacol 40: 287",
      "journal-title": "Eur J Clin Pharmacol"
    },
    {
      "key": "CR6",
      "doi-asserted-by": "crossref",
      "first-page": "147",
      "DOI": "10.1200/JCO.1986.4.2.147",
      "volume": "4",
      "author": "B Coiffier",
      "year": "1986",
      "unstructured": "Coiffier B, Bryon PA, Berger F, Arehimbaud E, French M, Extra JM, Guyotat D, Fiere D, Gentilhomme O, Magaud JP, Blanc M, Peaud PY, Vuvan H, Viala G (1986) Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80). J Clin Oncol 4: 147",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "CR7",
      "doi-asserted-by": "crossref",
      "first-page": "334",
      "DOI": "10.1111/j.1365-2141.1989.tb07749.x",
      "volume": "73",
      "author": "French Cooperative Group on Chronic Lymphocytic Leukemia",
      "year": "1989",
      "unstructured": "French Cooperative Group on Chronic Lymphocytic Leukemia (1989) Long-term results of the CHOP regimen in stage C chronic lymphocytic leukemia. Br J Hematol 73: 334",
      "journal-title": "Br J Hematol"
    },
    {
      "key": "CR8",
      "first-page": "1027",
      "volume": "68",
      "author": "R Ganapathi",
      "year": "1982",
      "unstructured": "Ganapathi R, Reiter W, Krishan A (1982) Intracellular Adriamycin levels and cytotoxicity in Adriamycin-sensitive and Adriamycin-resistant P388 mouse leukemia cells. J Natl Cancer Inst 68: 1027",
      "journal-title": "J Natl Cancer Inst"
    },
    {
      "key": "CR9",
      "first-page": "133",
      "volume": "57",
      "author": "MB Garnick",
      "year": "1983",
      "unstructured": "Garnick MB, Weiss GR, Steele GD, Israel M, Schade D, Sack MJ, Frei E (1983) Clinical evaluation of long-term continuous-infusion doxorubicin. Cancer Treat Rep 57: 133",
      "journal-title": "Cancer Treat Rep"
    },
    {
      "key": "CR10",
      "doi-asserted-by": "crossref",
      "first-page": "1133",
      "DOI": "10.1093/jnci/82.13.1133",
      "volume": "82",
      "author": "H Herweijer",
      "year": "1990",
      "unstructured": "Herweijer H, Sonneveld P, Baas F, Nooter F (1990) Expression of mdrl and mdr3 multi-drug resistance genes in acute and chronic leukemias and stimulation of drug accumulation by cyclosporine. J Natl Cancer Inst 82: 1133",
      "journal-title": "J Natl Cancer Inst"
    },
    {
      "key": "CR11",
      "doi-asserted-by": "crossref",
      "first-page": "19",
      "DOI": "10.1182/blood.V74.1.19.bloodjournal74119",
      "volume": "74",
      "author": "MJ Keating",
      "year": "1989",
      "unstructured": "Keating MJ, Kantarjiaian H, Talpaz M, Redman J, Koller C, Barlogie B, Velasquez W, Plunkett W, Freireich EJ, McCredie KB (1989) Fludarabine: a new agent with major activity against chronic lymphocytic leukemia. Blood 74: 19",
      "journal-title": "Blood"
    },
    {
      "key": "CR12",
      "doi-asserted-by": "crossref",
      "first-page": "133",
      "DOI": "10.7326/0003-4819-96-2-133",
      "volume": "96",
      "author": "SS Legha",
      "year": "1982",
      "unstructured": "Legha SS, Benjamin RS, Mackay B, Ewer M, Wallace S, Valdivieso M, Rasmussen SL, Blumenschein M, Freireich EJ (1982) Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann Intern Med 96: 133",
      "journal-title": "Ann Intern Med"
    },
    {
      "key": "CR13",
      "doi-asserted-by": "crossref",
      "first-page": "1484",
      "DOI": "10.1002/1097-0142(197610)38:4<1484::AID-CNCR2820380407>3.0.CO;2-I",
      "volume": "38",
      "author": "EM McKelvey",
      "year": "1976",
      "unstructured": "McKelvey EM, Gottlieb JA, Wilson HE, Haut A, Talley RW, Stephens R, Lane M, Gamble JF, Jones SE, Grozea PN, Guttermann J, Coltman C, Moon TE (1976) Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphomas. Cancer 38: 1484",
      "journal-title": "Cancer"
    },
    {
      "key": "CR14",
      "doi-asserted-by": "crossref",
      "first-page": "17",
      "DOI": "10.1200/JCO.1991.9.1.17",
      "volume": "9",
      "author": "TP Miller",
      "year": "1991",
      "unstructured": "Miller TP, Grogan TM, Dalton WS, Spier CM, Scheper RJ, Salmon SE (1991) P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high dose verapamil. J Clin Oncol 9: 17",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "CR15",
      "doi-asserted-by": "crossref",
      "first-page": "55",
      "DOI": "10.1159/000225791",
      "volume": "41",
      "author": "T Nguyen-Ngoc",
      "year": "1984",
      "unstructured": "Nguyen-Ngoc T, Vrignaud P, Robert J (1984) Cellular pharmacokinetics of doxorubicin in cultured mouse sarcoma cells originating from autochthonous tumors. Oncology 41: 55",
      "journal-title": "Oncology"
    },
    {
      "key": "CR16",
      "doi-asserted-by": "crossref",
      "first-page": "1069",
      "DOI": "10.1182/blood.V72.3.1069.bloodjournal7231069",
      "volume": "72",
      "author": "LD Piro",
      "year": "1988",
      "unstructured": "Piro LD, Carrera CJ, Beutler E, Carson DA (1988) 2-chloro-deoxyadenosine: an effective new agent for the treatment of chronic lymphocytic leukemia. Blood 72: 1069",
      "journal-title": "Blood"
    },
    {
      "key": "CR17",
      "doi-asserted-by": "crossref",
      "first-page": "50",
      "DOI": "10.1111/j.1365-2141.1991.tb08006.x",
      "volume": "79",
      "author": "C Shustik",
      "year": "1991",
      "unstructured": "Shustik C, Groulx N, Gros P (1991) Analysis of multidrug resistance (MDR-1) gene expression in chronic lymphocytic leukemia (CLL). Br J Haematol 79: 50",
      "journal-title": "Br J Haematol"
    },
    {
      "key": "CR18",
      "first-page": "305",
      "volume": "20",
      "author": "PA Speth",
      "year": "1987",
      "unstructured": "Speth PA, Linssen PC, Boezeman JB, Wessels H, Haanen C (1987a) Cellular and plasma adriamycin concentrations in longterm infusion therapy of leukemia patients. Cancer Chem Pharmacol 20: 305",
      "journal-title": "Cancer Chem Pharmacol"
    },
    {
      "key": "CR19",
      "first-page": "311",
      "volume": "20",
      "author": "PA Speth",
      "year": "1987",
      "unstructured": "Speth PA, Linssen PC, Boezeman JB, Wessels H, Haanen C (1987b) Leukemic cell and plasma daunomycin concentrations after bolus injection and 72 h infusion. Cancer Chem Pharmacol 20: 311",
      "journal-title": "Cancer Chem Pharmacol"
    },
    {
      "key": "CR20",
      "doi-asserted-by": "crossref",
      "first-page": "661",
      "DOI": "10.1038/clpt.1987.92",
      "volume": "41",
      "author": "PA Speth",
      "year": "1987",
      "unstructured": "Speth PA, Linssen PC, Holdriner RS, Haanen C (1987c) Plasma and cellular Adriamycin concentrations in patients with myeloma treated with ninety-six-hour continuous infusion. Clin Pharmacol Ther 41: 661",
      "journal-title": "Clin Pharmacol Ther"
    },
    {
      "key": "CR21",
      "first-page": "232a",
      "volume": "72",
      "author": "WS Velasquez",
      "year": "1988",
      "unstructured": "Velasquez WS, McLaughlin P, Alexanian R, Barlogie B, Swan F, Caballinas F (1988) Combination of dexamethasone, doxorubicin (Adriamycin) and vincristine (VAD) in chronic lymphocytic leukemia and diffuse small lymphocytic lymphoma. Blood 72: 232a",
      "journal-title": "Blood"
    }
  ],
  "container-title": "Cancer Chemotherapy and Pharmacology",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/BF00735923.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/BF00735923/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/BF00735923",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2020,
        4,
        4
      ]
    ],
    "date-time": "2020-04-04T13:51:39Z",
    "timestamp": 1586008299000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/BF00735923"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        1993,
        9
      ]
    ]
  },
  "references-count": 21,
  "journal-issue": {
    "issue": "5",
    "published-print": {
      "date-parts": [
        [
          1993,
          9
        ]
      ]
    }
  },
  "alternative-id": [
    "BF00735923"
  ],
  "URL": "http://dx.doi.org/10.1007/BF00735923",
  "relation": {},
  "ISSN": [
    "0344-5704",
    "1432-0843"
  ],
  "subject": [],
  "container-title-short": "Cancer Chemother. Pharmacol.",
  "published": {
    "date-parts": [
      [
        1993,
        9
      ]
    ]
  }
}